ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.280
+0.080 (2.50%)
Feb 2, 2026, 9:17 AM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €51.56 million as of February 2, 2026. Its market cap has increased by 6.67% in one year.
Market Cap
51.56M
Enterprise Value
53.33M
Revenue
6.23M
Ranking
n/a
PE Ratio
111.28
Stock Price
€3.28
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 51.56M, an increase of 1,955.92%. That is a compound annual growth rate of 12.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 51.56M | 6.67% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.46B |
| Sanofi | 95.74B |
| Sartorius Stedim Biotech | 18.32B |
| Eurofins Scientific SE | 12.03B |
| Affluent Medical | 77.52M |
| Valerio Therapeutics Société anonyme | 69.17M |
| Klea Holding | 67.08M |
| Fermentalg | 41.13M |